Tag: revascularisation

Endarterectomy and TCAR “continue to show superior outcomes” to transfemoral stenting

Researchers led by a vascular team in Indianapolis found that carotid endarterectomy (CEA) remains the most-used strategy in carotid revascularisation, with CEA and transcarotid...
carotid stenosis women

Carotid stenosis in women: Should the approach differ?

The existing evidence on whether women with carotid stenosis experience inferior treatment outcomes compared to men is mixed—and this uncertainty is reflected in the...
Xarelto

Data from new VOYAGER PAD analyses reinforce benefit of Xarelto plus...

The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced data from new analyses from the Phase 3 VOYAGER PAD clinical trial reinforcing the...
carotid artery stenosis

Study highlights need to extend scope of cerebrovascular health disparities research

A new research letter in Stroke outlines use of the novel National Institutes of Health (NIH) ‘All of Us’ research programme dataset of diverse...

Novel system-wide interdisciplinary team diverts patients from amputation and improves outcomes

Findings from a first-of-its-kind study conducted at University Hospitals (UH) Harrington Heart & Vascular Institute (Cleveland, USA) showed a novel system-wide interdisciplinary team assembled...

Study confirms efficiency of Upstream Peripheral’s GoBack catheter for complex lower...

Upstream Peripheral Technologies announced today that its GoBack catheter for crossing and re-entry was proven very effective for patients undergoing complex revascularisations in lower...

VOYAGER PAD subanalysis highlights risks for claudicants undergoing revascularisation

Principal investigator of the VOYAGER PAD trial, Marc Bonaca (University of Colorado Anschutz Medical Campus, Aurora, USA) speaks to Vascular News about the latest data...
PAD

Hispanic adults with PAD access inpatient care most often via the...

Hispanic adults hospitalised for treatment of symptoms of peripheral arterial disease (PAD) were more likely to access this care by going to the emergency...

Systematic review and meta-analysis finds “substantial” one-year mortality rate in octogenarians...

In octogenarians with chronic limb-threatening ischaemia (CLTI), researchers found a one-year mortality rate of 32% after revascularisation, which was significantly higher than in non-octogenarians....

ESC/ESVS consensus document gives clear recommendations for following up patients after...

New guidance on monitoring patients after revascularisation for peripheral arterial diseases (PAD) has been produced by the European Society of Cardiology (ESC) Working Group...
paclitaxel

Full revascularisation “may not be the best solution” for CLI patients

Aiming for full revascularisation “may not be the best solution” for treating patients with critical limb ischaemia (CLI) according to Thomas Zeller (Bad Krozingen,...

ESVS 2019: HT-CLI trial to definitively test if cell technology can...

Bijan Modarai (London, UK) talks to BLearning Peripheral at ESVS 2019 (European Society for Vascular Surgery; 24–27 September; Hamburg, Germany) about the HT-CLI trial, which will look at the...

Customising therapy in femoropopliteal revascularisation

 Gary Ansel (Columbus, USA) tells Vascular News at VEITHSymposium 2018 about how drug-based therapies have become a mainstay in femoropopliteal revascularisation and how interventionalists...

LINC 2018 data highlight IN.PACT Admiral as safe and effective treatment...

Medtronic added to its body of clinical evidence supporting the IN.PACT Admiral drug-coated balloon with new presentations that demonstrated durable and consistent clinical outcomes...

Surgery-first approach for critical limb ischaemia offers faster wound healing rate...

A surgical-first strategy appears to be superior to endovascular treatment for critical limb ischaemia revascularisation, exhibiting improved wound healing rate and overall healing time,...

LimFlow receives CE mark for percutaneous critical limb perfusion system

LimFlow has received CE mark for its fully percutaneous LimFlow system designed for venous arterialisation of the lower limbs in end-stage patients at risk...